Clinical Trials Directory

Trials / Completed

CompletedNCT03964636

Contraceptive Pills and Retinal Vascularization

Contraceptive Pills and Retinal Vascularization (Piluret)

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
Female
Age
18 Years
Healthy volunteers

Summary

The main hypothesis is the taking of combined 1st and 2nd generation or 3rd and 4th generation oral contraceptives is associated with a change in retinal micro-vascularization compared to the absence of combined oral contraceptive intake. Women of childbearing age will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to their medical and ophthalmologic history and their oestro-progestative contraceptive intake will be collected. The objective is to find an association between retinal vascular density and combined oral contraceptives intake.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOCT-A (optical coherence tomography)Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.

Timeline

Start date
2019-07-17
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-05-28
Last updated
2023-02-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03964636. Inclusion in this directory is not an endorsement.